SCHEMBL30740985

SCHEMBL30740985

N#C/C(C(=O)C1CC1)=C(/O)c1ccc(O)c(C#N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 1/20 0.48
SLC22A12 Q96S37 4/20 0.40
XDH P47989 1/20 0.40
GCGR P47871 4/20 0.36
HTT P42858 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
DHODH Q02127 1/20 0.34
FAAH O00519 1/20 0.34
F11 P03951 1/20 0.33
CYP2C9 P11712 1/20 0.33
RGS12 O14924 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669777 0.77 SLC22A12 (0.43) FTOSLC22A12XDHGCGRMEN1
SCHEMBL32670060 0.75 COMT (0.43) FTOSLC22A12XDHGCGRALDH1A1
SCHEMBL32669956 0.74 COMT (0.55) FTOSLC22A12XDHGCGRMEN1
SCHEMBL32670120 0.73 FTO (0.54) FTOSLC22A12HTTKDM4EMEN1
SCHEMBL106260 0.72 XDH (0.61) SLC22A12XDHHTTKDM4EALDH1A1
SCHEMBL17663953 0.71 SLC22A12 (0.49) SLC22A12XDHGCGRF11
SCHEMBL7942553 0.68 PKM (0.50) SLC22A12XDHGCGRHTTMEN1
SCHEMBL32669869 0.66 RAB9A (0.42) SLC22A12MEN1KMT2ARAB9A
SCHEMBL32669845 0.65 FTO (0.72) FTOKDM4EMEN1ALDH1A1LMNA
SCHEMBL22840484 0.65 HPGD (0.58) SLC22A12HTTALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885SLC22A12 1753/4885XDH 1523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.